eli lilly glp-1 drugs FDA approves Foundayo, an oral alternative to Wegovy and Ozempic glp 1 zepbound Eli Lilly's

doi: 10.1002/jcb.24425 72 WangYGYangTL

The presence of severe nonproliferative DR or proliferative DR requires comanagement with retinology and further intervention, including intravitreal injection and/or laser photocoagulation consistent with the clinical standard of care

BI 456906: discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy

Cancers (Basel) 6 , 926957 (2014)

Firstly because of the abundance of GLP-1 receptors in the brain, and secondly because the brain and the immune system communicate with all organs in the body (Lunenfeld-Tanenbaum Research Institute)